Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30 entries
Sorted by: Best Match Show Resources per page
Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel.

Open forum infectious diseases

Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ.
PMID: 25884004
Open Forum Infect Dis. 2015 Jan 03;2(1):ofu115. doi: 10.1093/ofid/ofu115. eCollection 2015 Jan.

Background.  Most inactivated influenza vaccines contain purified and standardized hemagglutinin (HA) and residual neuraminidase (NA) antigens. Vaccine-associated HA antibody responses (hemagglutination inhibition [HAI]) are well described, but less is known about the immune response to the NA. Methods.  Serum...

Cite
Laguio-Vila MR, Thompson MG, Reynolds S, et al. Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open Forum Infect Dis. 2015;2(1):ofu115doi: 10.1093/ofid/ofu115.
Laguio-Vila, M. R., Thompson, M. G., Reynolds, S., Spencer, S. M., Gaglani, M., Naleway, A., Ball, S., Bozeman, S., Baker, S., Martínez-Sobrido, L., Levine, M., Katz, J., Fry, A. M., & Treanor, J. J. (2015). Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open forum infectious diseases, 2(1), ofu115. https://doi.org/10.1093/ofid/ofu115
Laguio-Vila, Maryrose R, et al. "Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel." Open forum infectious diseases vol. 2,1 (2015): ofu115. doi: https://doi.org/10.1093/ofid/ofu115
Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ. Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open Forum Infect Dis. 2015 Jan 03;2(1):ofu115. doi: 10.1093/ofid/ofu115. eCollection 2015 Jan. PMID: 25884004; PMCID: PMC4396428.
Copy Download .nbib Format: NLM
Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study.

JMIR research protocols

Naleway AL, Ball S, Kwong JC, Wyant BE, Katz MA, Regan AK, Russell ML, Klein NP, Chung H, Simmonds KA, Azziz-Baumgartner E, Feldman BS, Levy A, Fell DB, Drews SJ, Garg S, Effler P, Barda N, Irving SA, Shifflett P, Jackson ML, Thompson MG.
PMID: 30664495
JMIR Res Protoc. 2019 Jan 21;8(1):e11333. doi: 10.2196/11333.

BACKGROUND: Although pregnant women are believed to have elevated risks of severe influenza infection and are targeted for influenza vaccination, no study to date has examined influenza vaccine effectiveness (IVE) against laboratory-confirmed influenza-associated hospitalizations during pregnancy, primarily because this...

Cite
Naleway AL, Ball S, Kwong JC, et al. Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study. JMIR Res Protoc. 2019;8(1):e11333doi: 10.2196/11333.
Naleway, A. L., Ball, S., Kwong, J. C., Wyant, B. E., Katz, M. A., Regan, A. K., Russell, M. L., Klein, N. P., Chung, H., Simmonds, K. A., Azziz-Baumgartner, E., Feldman, B. S., Levy, A., Fell, D. B., Drews, S. J., Garg, S., Effler, P., Barda, N., Irving, S. A., Shifflett, P., Jackson, M. L., & Thompson, M. G. (2019). Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study. JMIR research protocols, 8(1), e11333. https://doi.org/10.2196/11333
Naleway, Allison L, et al. "Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study." JMIR research protocols vol. 8,1 (2019): e11333. doi: https://doi.org/10.2196/11333
Naleway AL, Ball S, Kwong JC, Wyant BE, Katz MA, Regan AK, Russell ML, Klein NP, Chung H, Simmonds KA, Azziz-Baumgartner E, Feldman BS, Levy A, Fell DB, Drews SJ, Garg S, Effler P, Barda N, Irving SA, Shifflett P, Jackson ML, Thompson MG. Estimating Vaccine Effectiveness Against Hospitalized Influenza During Pregnancy: Multicountry Protocol for a Retrospective Cohort Study. JMIR Res Protoc. 2019 Jan 21;8(1):e11333. doi: 10.2196/11333. PMID: 30664495; PMCID: PMC6360380.
Copy Download .nbib Format: NLM
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.

Vaccine

Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S.
PMID: 34906392
Vaccine. 2021 Dec 11; doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11.

INTRODUCTION: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.METHODS: Initiated in July 2020, the HEROES-RECOVER cohort...

Cite
Lutrick K, Groom H, Fowlkes AL, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021;doi: 10.1016/j.vaccine.2021.11.094.
Lutrick, K., Groom, H., Fowlkes, A. L., Groover, K. D., Gaglani, M., Rivers, P., Naleway, A. L., Nguyen, K., Herring, M., Dunnigan, K., Phillips, A., Parker, J., Mayo Lamberte, J., Prather, K., Thiese, M. S., Baccam, Z., Tyner, H., & Yoon, S. (2021). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, . https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick, Karen, et al. "COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers." Vaccine vol. (2021). doi: https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021 Dec 11; doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. PMID: 34906392.
Copy Download .nbib Format: NLM
Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Dawood FS, Naleway AL, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards L, Ball S, Grant L, Belongia E, Bounds K, Cao W, Gross FL, Groom H, Fry AM, Rentz Hunt D, Jeddy Z, Mishina M, Kim SS, Wesley MG, Spencer S, Thompson MG, Gaglani M.
PMID: 34245243
Clin Infect Dis. 2021 Dec 06;73(11):1973-1981. doi: 10.1093/cid/ciab566.

BACKGROUND: RIV4 and cell-culture based inactivated influenza vaccine (ccIIV4) have not been compared to egg-based IIV4 in healthcare personnel, a population with frequent influenza vaccination that may blunt vaccine immune responses over time. We conducted a randomized trial among...

Cite
Dawood FS, Naleway AL, Flannery B, et al. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. Clin Infect Dis. 2021;73(11):1973-1981doi: 10.1093/cid/ciab566.
Dawood, F. S., Naleway, A. L., Flannery, B., Levine, M. Z., Murthy, K., Sambhara, S., Gangappa, S., Edwards, L., Ball, S., Grant, L., Belongia, E., Bounds, K., Cao, W., Gross, F. L., Groom, H., Fry, A. M., Rentz Hunt, D., Jeddy, Z., Mishina, M., Kim, S. S., Wesley, M. G., Spencer, S., Thompson, M. G., & Gaglani, M. (2021). Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), 1973-1981. https://doi.org/10.1093/cid/ciab566
Dawood, Fatimah S, et al. "Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): 1973-1981. doi: https://doi.org/10.1093/cid/ciab566
Dawood FS, Naleway AL, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards L, Ball S, Grant L, Belongia E, Bounds K, Cao W, Gross FL, Groom H, Fry AM, Rentz Hunt D, Jeddy Z, Mishina M, Kim SS, Wesley MG, Spencer S, Thompson MG, Gaglani M. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. Clin Infect Dis. 2021 Dec 06;73(11):1973-1981. doi: 10.1093/cid/ciab566. PMID: 34245243; PMCID: PMC8499731.
Copy Download .nbib Format: NLM
Impact Protection Potential of Mammalian Hair: Testing the Pugilism Hypothesis for the Evolution of Human Facial Hair.

Integrative organismal biology (Oxford, England)

Beseris EA, Naleway SE, Carrier DR.
PMID: 33791549
Integr Org Biol. 2020 Apr 15;2(1):obaa005. doi: 10.1093/iob/obaa005. eCollection 2020.

Because facial hair is one of the most sexually dimorphic features of humans (

Cite
Beseris EA, Naleway SE, Carrier DR. Impact Protection Potential of Mammalian Hair: Testing the Pugilism Hypothesis for the Evolution of Human Facial Hair. Integr Org Biol. 2020;2(1):obaa005doi: 10.1093/iob/obaa005.
Beseris, E. A., Naleway, S. E., & Carrier, D. R. (2020). Impact Protection Potential of Mammalian Hair: Testing the Pugilism Hypothesis for the Evolution of Human Facial Hair. Integrative organismal biology (Oxford, England), 2(1), obaa005. https://doi.org/10.1093/iob/obaa005
Beseris, E A, et al. "Impact Protection Potential of Mammalian Hair: Testing the Pugilism Hypothesis for the Evolution of Human Facial Hair." Integrative organismal biology (Oxford, England) vol. 2,1 (2020): obaa005. doi: https://doi.org/10.1093/iob/obaa005
Beseris EA, Naleway SE, Carrier DR. Impact Protection Potential of Mammalian Hair: Testing the Pugilism Hypothesis for the Evolution of Human Facial Hair. Integr Org Biol. 2020 Apr 15;2(1):obaa005. doi: 10.1093/iob/obaa005. eCollection 2020. PMID: 33791549; PMCID: PMC7671116.
Copy Download .nbib Format: NLM
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.

Vaccine

Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S.
PMID: 34906392
Vaccine. 2021 Dec 11; doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11.

INTRODUCTION: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.METHODS: Initiated in July 2020, the HEROES-RECOVER cohort...

Cite
Lutrick K, Groom H, Fowlkes AL, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021;doi: 10.1016/j.vaccine.2021.11.094.
Lutrick, K., Groom, H., Fowlkes, A. L., Groover, K. D., Gaglani, M., Rivers, P., Naleway, A. L., Nguyen, K., Herring, M., Dunnigan, K., Phillips, A., Parker, J., Mayo Lamberte, J., Prather, K., Thiese, M. S., Baccam, Z., Tyner, H., & Yoon, S. (2021). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, . https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick, Karen, et al. "COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers." Vaccine vol. (2021). doi: https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021 Dec 11; doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. PMID: 34906392; PMCID: PMC8665770.
Copy Download .nbib Format: NLM
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems.

Vaccine

Groom HC, Crane B, Naleway AL, Weintraub E, Daley MF, Wain K, Beth Kurilo M, Burganowski R, DeSilva MB, Donahue JG, Glenn SC, Goddard K, Jackson ML, Kharbanda EO, Lewis N, Lou Y, Lugg M, Scotty E, Sy LS, Williams JTB, Irving SA.
PMID: 34980508
Vaccine. 2021 Dec 31; doi: 10.1016/j.vaccine.2021.12.048. Epub 2021 Dec 31.

BACKGROUND: The Vaccine Safety Datalink (VSD) uses vaccination data from electronic health records (EHR) at eight integrated health systems to monitor vaccine safety. Accurate capture of data from vaccines administered outside of the health system is critical for vaccine...

Cite
Groom HC, Crane B, Naleway AL, et al. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems. Vaccine. 2021;doi: 10.1016/j.vaccine.2021.12.048.
Groom, H. C., Crane, B., Naleway, A. L., Weintraub, E., Daley, M. F., Wain, K., Beth Kurilo, M., Burganowski, R., DeSilva, M. B., Donahue, J. G., Glenn, S. C., Goddard, K., Jackson, M. L., Kharbanda, E. O., Lewis, N., Lou, Y., Lugg, M., Scotty, E., Sy, L. S., Williams, J. T. B., & Irving, S. A. (2021). Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems. Vaccine, . https://doi.org/10.1016/j.vaccine.2021.12.048
Groom, Holly C, et al. "Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems." Vaccine vol. (2021). doi: https://doi.org/10.1016/j.vaccine.2021.12.048
Groom HC, Crane B, Naleway AL, Weintraub E, Daley MF, Wain K, Beth Kurilo M, Burganowski R, DeSilva MB, Donahue JG, Glenn SC, Goddard K, Jackson ML, Kharbanda EO, Lewis N, Lou Y, Lugg M, Scotty E, Sy LS, Williams JTB, Irving SA. Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems. Vaccine. 2021 Dec 31; doi: 10.1016/j.vaccine.2021.12.048. Epub 2021 Dec 31. PMID: 34980508; PMCID: PMC8719644.
Copy Download .nbib Format: NLM
The melanized layer of Armillaria ostoyae rhizomorphs: Its protective role and functions.

Journal of the mechanical behavior of biomedical materials

Porter DL, Bradshaw AJ, Nielsen RH, Newell P, Dentinger BTM, Naleway SE.
PMID: 34773913
J Mech Behav Biomed Mater. 2022 Jan;125:104934. doi: 10.1016/j.jmbbm.2021.104934. Epub 2021 Oct 27.

Armillaria ostoyae (Romagn.) Herink is a highly pathogenic fungus that uses exploratory, cordlike structures called rhizomorphs to seek out new sources of nutrition, posing a parasitic threat to natural stands of trees, orchards, and vineyards. Rhizomorphs are notoriously difficult...

Cite
Porter DL, Bradshaw AJ, Nielsen RH, et al. The melanized layer of Armillaria ostoyae rhizomorphs: Its protective role and functions. J Mech Behav Biomed Mater. 2021;125:104934doi: 10.1016/j.jmbbm.2021.104934.
Porter, D. L., Bradshaw, A. J., Nielsen, R. H., Newell, P., Dentinger, B. T. M., & Naleway, S. E. (2022). The melanized layer of Armillaria ostoyae rhizomorphs: Its protective role and functions. Journal of the mechanical behavior of biomedical materials, 125104934. https://doi.org/10.1016/j.jmbbm.2021.104934
Porter, Debora Lyn, et al. "The melanized layer of Armillaria ostoyae rhizomorphs: Its protective role and functions." Journal of the mechanical behavior of biomedical materials vol. 125 (2022): 104934. doi: https://doi.org/10.1016/j.jmbbm.2021.104934
Porter DL, Bradshaw AJ, Nielsen RH, Newell P, Dentinger BTM, Naleway SE. The melanized layer of Armillaria ostoyae rhizomorphs: Its protective role and functions. J Mech Behav Biomed Mater. 2022 Jan;125:104934. doi: 10.1016/j.jmbbm.2021.104934. Epub 2021 Oct 27. PMID: 34773913.
Copy Download .nbib Format: NLM
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.

Vaccine

Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S.
PMID: 34906392
Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11.

INTRODUCTION: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.METHODS: Initiated in July 2020, the HEROES-RECOVER cohort...

Cite
Lutrick K, Groom H, Fowlkes AL, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021;40(3):494-502doi: 10.1016/j.vaccine.2021.11.094.
Lutrick, K., Groom, H., Fowlkes, A. L., Groover, K. D., Gaglani, M., Rivers, P., Naleway, A. L., Nguyen, K., Herring, M., Dunnigan, K., Phillips, A., Parker, J., Mayo Lamberte, J., Prather, K., Thiese, M. S., Baccam, Z., Tyner, H., & Yoon, S. (2022). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, 40(3), 494-502. https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick, Karen, et al. "COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers." Vaccine vol. 40,3 (2022): 494-502. doi: https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. PMID: 34906392; PMCID: PMC8665770.
Copy Download .nbib Format: NLM
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.

Vaccine

Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S.
PMID: 34906392
Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11.

INTRODUCTION: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.METHODS: Initiated in July 2020, the HEROES-RECOVER cohort...

Cite
Lutrick K, Groom H, Fowlkes AL, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021;40(3):494-502doi: 10.1016/j.vaccine.2021.11.094.
Lutrick, K., Groom, H., Fowlkes, A. L., Groover, K. D., Gaglani, M., Rivers, P., Naleway, A. L., Nguyen, K., Herring, M., Dunnigan, K., Phillips, A., Parker, J., Mayo Lamberte, J., Prather, K., Thiese, M. S., Baccam, Z., Tyner, H., & Yoon, S. (2022). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, 40(3), 494-502. https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick, Karen, et al. "COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers." Vaccine vol. 40,3 (2022): 494-502. doi: https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2022 Jan 24;40(3):494-502. doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. PMID: 34906392; PMCID: PMC8665770.
Copy Download .nbib Format: NLM
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.

Vaccine

Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S.
PMID: 34906392
Vaccine. 2021 Dec 11; doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11.

INTRODUCTION: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time.METHODS: Initiated in July 2020, the HEROES-RECOVER cohort...

Cite
Lutrick K, Groom H, Fowlkes AL, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021;doi: 10.1016/j.vaccine.2021.11.094.
Lutrick, K., Groom, H., Fowlkes, A. L., Groover, K. D., Gaglani, M., Rivers, P., Naleway, A. L., Nguyen, K., Herring, M., Dunnigan, K., Phillips, A., Parker, J., Mayo Lamberte, J., Prather, K., Thiese, M. S., Baccam, Z., Tyner, H., & Yoon, S. (2021). COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine, . https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick, Karen, et al. "COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers." Vaccine vol. (2021). doi: https://doi.org/10.1016/j.vaccine.2021.11.094
Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, Baccam Z, Tyner H, Yoon S. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. 2021 Dec 11; doi: 10.1016/j.vaccine.2021.11.094. Epub 2021 Dec 11. PMID: 34906392; PMCID: PMC8665770.
Copy Download .nbib Format: NLM
Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Tyner HL, Burgess JL, Grant L, Gaglani M, Kuntz JL, Naleway AL, Thornburg NJ, Caban-Martinez AJ, Yoon SK, Herring MK, Beitel SC, Blanton L, Nikolich-Zugich J, Thiese MS, Pleasants JF, Fowlkes AL, Lutrick K, Dunnigan K, Yoo YM, Rose S, Groom H, Meece J, Wesley MG, Schaefer-Solle N, Louzado-Feliciano P, Edwards LJ, Olsho LEW, Thompson MG.
PMID: 34928334
Clin Infect Dis. 2021 Dec 20; doi: 10.1093/cid/ciab1038. Epub 2021 Dec 20.

BACKGROUND: Data on the development of neutralizing antibodies against SARS-CoV-2 after SARS-CoV-2 infection and after vaccination with messenger RNA (mRNA) COVID-19 vaccines are limited.METHODS: From a prospective cohort of 3,975 adult essential and frontline workers tested weekly from August...

Cite
Tyner HL, Burgess JL, Grant L, et al. Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection. Clin Infect Dis. 2021;doi: 10.1093/cid/ciab1038.
Tyner, H. L., Burgess, J. L., Grant, L., Gaglani, M., Kuntz, J. L., Naleway, A. L., Thornburg, N. J., Caban-Martinez, A. J., Yoon, S. K., Herring, M. K., Beitel, S. C., Blanton, L., Nikolich-Zugich, J., Thiese, M. S., Pleasants, J. F., Fowlkes, A. L., Lutrick, K., Dunnigan, K., Yoo, Y. M., Rose, S., Groom, H., Meece, J., Wesley, M. G., Schaefer-Solle, N., Louzado-Feliciano, P., Edwards, L. J., Olsho, L. E. W., & Thompson, M. G. (2021). Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, . https://doi.org/10.1093/cid/ciab1038
Tyner, Harmony L, et al. "Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. (2021). doi: https://doi.org/10.1093/cid/ciab1038
Tyner HL, Burgess JL, Grant L, Gaglani M, Kuntz JL, Naleway AL, Thornburg NJ, Caban-Martinez AJ, Yoon SK, Herring MK, Beitel SC, Blanton L, Nikolich-Zugich J, Thiese MS, Pleasants JF, Fowlkes AL, Lutrick K, Dunnigan K, Yoo YM, Rose S, Groom H, Meece J, Wesley MG, Schaefer-Solle N, Louzado-Feliciano P, Edwards LJ, Olsho LEW, Thompson MG. Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection. Clin Infect Dis. 2021 Dec 20; doi: 10.1093/cid/ciab1038. Epub 2021 Dec 20. PMID: 34928334; PMCID: PMC8755309.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30 entries